SCM
HLVX

Sterling Capital Management’s HilleVax HLVX Stock Holding History

Sterling Capital Management’s Portfolio HLVX Stock Details HLVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-442
Closed -$641 – 3315
2025
Q1 		$641 Sell
442
-405
-48% -$749 ﹤0.01% 2924
2024
Q4 		$1.75K Buy
847
+760
+874% +$1.43K ﹤0.01% 2814
2024
Q3 		$153 Buy
+87
New +$223 ﹤0.01% 3146

Other funds holding HLVX

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
TPC
Takeda Pharmaceutical Company Tokyo, Japan $16.4M AUM 195.92% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
LMC
Lightspeed Management Company Menlo Park, California $988M AUM 7.5% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Sterling Capital Management's HLVX Position: Q2 2025 in Review

Sterling Capital Management sold out of HilleVax (HLVX) in Q2 2025, closing a stake of 442 shares — an estimated $641 sold.

Sterling Capital Management first reported a position in HLVX in Q3 2024 and held it in 3 quarters. The position peaked at $1.75K in Q4 2024. 74 funds tracked by Wall St. Rank hold HLVX as of Q2 2025.

  • Sterling Capital Management reported no remaining HilleVax position as of Q2 2025 after selling out during the quarter.
  • Sterling Capital Management sold 442 HilleVax shares in Q2 2025, an estimated $641.
  • Sterling Capital Management first reported a position in HilleVax in Q3 2024 and held it in 3 quarters.
  • Sterling Capital Management's HilleVax position peaked at $1.75K in Q4 2024.
  • 74 funds tracked by Wall St. Rank held HilleVax as of Q2 2025.

Based on Sterling Capital Management's 13F filing for Q2 2025, filed 6 Aug 2025.